Impax Laboratories Inc. (IPXL) Reports Q4 EPS of $0.33, Sales Top Expectations
Tweet
Share
E-mailGet Alerts IPXL Hot Sheet
Price: $18.30 --0%
Financial Fact:
Net income before noncontrolling interest: -179.34M
Today's EPS Names:
FWDI, GO, BATL, More
Financial Fact:
Net income before noncontrolling interest: -179.34M
Today's EPS Names:
FWDI, GO, BATL, More
Join SI Premium – FREE
Impax Laboratories Inc. (NASDAQ: IPXL) reported Q4 EPS of $0.33, which may not compare to the analyst estimate of $0.22. Revenue for the quarter came in at $158.6 million versus the consensus estimate of $128.51 million.
For earnings history and earnings-related data on Impax Laboratories Inc. (IPXL) click here.
For earnings history and earnings-related data on Impax Laboratories Inc. (IPXL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Okta upgraded as AI security opportunity boosts outlook
- First Watch (FWRG) Reiterated at Buy by DA Davidson: Potential for Same-Store-Sales Upside
- Quantinuum Inc (QNT) PT Raised to $95 at Bernstein SocGen Group
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
